Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors.
- Published In:
- PET clinics, 19(3), 341-349 (2024)
- Authors:
- Bhimaniya, Sudhir, Shah, Hina, Jacene, Heather A
- Database ID:
- RPEP-07856
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07856APA
Bhimaniya, Sudhir; Shah, Hina; Jacene, Heather A. (2024). Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors.. PET clinics, 19(3), 341-349. https://doi.org/10.1016/j.cpet.2024.03.005
MLA
Bhimaniya, Sudhir, et al. "Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors.." PET clinics, 2024. https://doi.org/10.1016/j.cpet.2024.03.005
RethinkPeptides
RethinkPeptides Research Database. "Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuro..." RPEP-07856. Retrieved from https://rethinkpeptides.com/research/bhimaniya-2024-alphaemitter-peptide-receptor-radionuclide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.